NCT05811780 The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry
| NCT ID | NCT05811780 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Freiburg |
| Condition | Medical Condition Requiring Extracorporeal Organ Support |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2014-04-29 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2014-04-29 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective registry collecting pseudonymized clinical and treatment data from all patients treated with extracorporeal organ support (i.e., VV ECMO, VA ECMO, ECPR, Impella, IABP, and others) on the wards of the Department of Interdisciplinary Medical Intensive Care at the Freiburg University Medical Center.
Eligibility Criteria
Inclusion Criteria: * Treatment with any kind of extracorporeal organ support Exclusion Criteria: * none
Contact & Investigator
Tobias Wengenmayer, Prof. Dr.
STUDY DIRECTOR
University of Freiburg
Frequently Asked Questions
Who can join the NCT05811780 clinical trial?
This trial is open to participants of all sexes, studying Medical Condition Requiring Extracorporeal Organ Support. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05811780 currently recruiting?
Yes, NCT05811780 is actively recruiting participants. Contact the research team at tobias.wengenmayer@uniklinik-freiburg.de for enrollment information.
Where is the NCT05811780 trial being conducted?
This trial is being conducted at Freiburg im Breisgau, Germany.
Who is sponsoring the NCT05811780 clinical trial?
NCT05811780 is sponsored by University Hospital Freiburg. The principal investigator is Tobias Wengenmayer, Prof. Dr. at University of Freiburg. The trial plans to enroll 1,500 participants.